SPOTLIGHT -
EuropaBio Calls for Strengthening of SME Biotech Sector
February 28, 2017
Big Data, Big Opportunities in Life Sciences
Rheumatoid Arthritis Market to Hit $28.5 Billion by 2025
February 23, 2017
Europe "Must Adopt the CETA Manufacturing Waiver "
February 22, 2017
EFPIA Confirms New Director General Appointment
FDA Promotes Diversity in Clinical Trials
February 17, 2017
The Broad Institute Triumphs in CRISPR Patent Battle
Manufacturers "Must Address Low Medication Compliance Among Lupus Patients"
Not Your Typical Pharma Dateline
Recent events you may have missed on the global pharma scene.
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
London School of Economics Establishes Market Access Academy
January 24, 2017
A High-Touch Approach to Product Access
Transformation Initiatives Underway for Regulatory Information Management
Top Tweets from J.P. Morgan 2017
Pharm Exec is back at the 2017 J.P. Morgan Healthcare Conference in San Francisco, CA.
Win Your Brand with Action
The seven ways for pharmas to ensure successful execution of action steps following brand "war games."
Pharmaceutical Executive, January 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2017 issue in an interactive PDF format.
Electrical Pulses Spark New Ways to Treat Diseases
Anthony Arnold offers an overview and update of bioelectronic medicine.
Will NICE ‘Go Commercial’?
That may be one option as the UK agency, like the NIH it supports, looks at how to generate big savings.
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Andrew Witty: Volume is Not a Dirty Word
“Volume is not a dirty word” was outgoing GSK head Sir Andrew Witty’s key message at last week’s FT Global Pharmaceutical Conference in London.
The Cancer Care Conundrum in Europe
Cancer treatment is an increasing dilemma for EU health services as they try to balance patient care against budgetary constraints.
Has Gastein Peaked?
This year’s 19th annual European Health Forum Gastein (Austria) once again attempted to establish unity in the face of EU woes. But are the Gastein region’s “healing powers” on the wane?
Pharmaceutical Executive, November 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
PE Media Planner 2017
New Challenge to IP Innovation
Survey on the rising use of Inter Partes Reviews to challenge patents reveals key considerations for originator companies.
Major Changes Ahead for Drug User Fees
PDUFA VI to enhance FDA staffing, revise fees and expand evidence for drug development.
Pharmaceutical Executive, October 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2016 issue in an interactive PDF format.
Managing Medication Adherence to Improve Clinical Trial Quality
CETA in the Balance
Can pharma help to salvage the EU's Comprehensive Economic and Trade Agreement with Canada in the face of resistance? Reflector reports.
New GSK Chief Will Be "Most Powerful" UK Female CEO
Emma Walmsley will succeed Andrew Witty next year and become the seventh female chief executive in the FTSE 100.
